Johnson & Johnson’s RYBREVANT® Shows Promising Results in Lung Cancer Study
RYBREVANT®Johnson’s with chemotherapy shows improved survival outcomes for EGFR-mutated NSCLC patients in Johnson & Johnson’s Phase 3 MARIPOSA-2 study.
RYBREVANT®Johnson’s with chemotherapy shows improved survival outcomes for EGFR-mutated NSCLC patients in Johnson & Johnson’s Phase 3 MARIPOSA-2 study.
The 11th Annual Women’s Venture Summit will occur in San Diego from September 25-27, 2024, featuring trailblazing speakers Arian Simone and Elizabeth Gore.
Grit Biotechnology secures FDA approval for GT201, a cutting-edge cancer therapy advancing clinical trials in the U.S. and China.
Coofandy and Ekouaer debut in NYFW, showcasing innovative menswear and stylish sleepwear. Find their journey from Amazon to the global fashion stage.
Sungrow hits the 20 GW milestone in Latin America and unveils new solar, storage, and EV solutions at Intersolar South America 2024, driving regional decarbonization.
Noah Holdings reports strong Q2 2024 results with accelerated overseas expansion and a new share repurchase program.
Sungrow reports strong growth in 2024, with revenue up 8.38%. The global leader in renewable energy continues to drive innovation and sustainability.
GCL SI joins ABSOLAR at Intersolar South America 2024, strengthening its commitment to Brazil’s solar energy market with innovative, low-carbon solutions.
Restaurantware launches the Sustain collection, offering fully compostable food packaging solutions in the U.S., made from bamboo and plant-based materials.
Express Legal Funding launches LFAFF, a coalition to promote transparency and ethical practices in legal funding, empower law firms, and protect plaintiffs.